Eugene

[email protected]

LATEST

Novartis To Spin Off Eye-Care Division Alcon; Initiates Share Buyback of up to $5 Billion
By

By
Novartis announced that it plans to spin off Alcon, its eye-care division, into a stand-alone company. The company is also planning to initiate a share buyback of up to $5…

Biogen Invests $700 Million To Increase Stake in Biosimilars JV Samsung Bioepis
By

By
Biogen has exercised its option to purchase additional shares of Samsung Bioepis, its biosimilars joint venture with Samsung BioLogics, an Incheon, South Korea-based contract biologics manufacturer, in a deal worth…

Sanofi To Launch R&D Operations Hub in China
By

By
Sanofi has announced plans to launch a global research and development (R&D) operations hub with a specialized focus on digitalization and Big Data analysis in Chengdu, Sichuan Province, China. It…

Merck & Co. Leads Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Merck & Co. Editor’s Note: This article was updated on a continuous basis…

Merck & Co. Leads Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Merck & Co. Editor’s Note: This article was updated on a continuous basis for news announced…

BridgeBio Pharma Launches Biopharm Company for Rare Genetic Disorders
By

By
BridgeBio Pharma, a Palo Alto, California-based clinical-stage biopharmaceutical company, has launched CoA Therapeutics, a biopharmaceutical company developing small-molecules designed to increase Coenzyme-A (CoA) levels in genetic disorders where CoA deficiency…

J&J Makes Executive Changes
By

By
Johnson & Johnson (J&J) has announced the appointment of several senior leaders to the company’s Executive Committee. The move includes the appointment of Joaquin Duato, Executive Vice President, Worldwide Chairman,…

Amazon To Acquire Online Pharmacy PillPack
By

By
In a move impacting the pharmacy business, the online retailer Amazon has agreed to acquire PillPack, an online pharmacy in the US that offers pre-sorted doses of medications for home…

Shire Receives FDA Approval for New Plasma Manufacturing Facility
By

By
The US Food and Drug Administration (FDA) has approved Shire’s submission for its new plasma manufacturing facility near Covington, Georgia for producing Gammagard Liquid [immune globulin infusion (human)] 10% Solution,…

Sanofi To Sell European Generics Business for $2.2 Billion
By

By
Sanofi and Advent International, a Boston-based private-equity firm, have finished negotiations for Advent’s acquisition of Zentiva, Sanofi’s European generics business, after signing a share purchase agreement worth EUR 1.9 billion…